Quote | XORTX Therapeutics Inc. (NASDAQ:XRTX)
Last: | $1.7619 |
---|---|
Change Percent: | 1.7% |
Open: | $1.8382 |
Close: | $1.7619 |
High: | $1.8382 |
Low: | $1.7619 |
Volume: | 2,984 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | XORTX Therapeutics Inc. (NASDAQ:XRTX)
CALGARY, June 04, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to anno...
2024-05-20 11:53:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips XORTX Therapeutics (NASDAQ: XRTX ) just reported results for the first quarter of 2024. XORTX Therapeutics reported earnings per share of -$1.24. The company did not r...
Message Board Posts | XORTX Therapeutics Inc. (NASDAQ:XRTX)
Subject | By | Source | When |
---|---|---|---|
Today(as of now), premarket trading is normal which | Max2121 | investorshub | 01/20/2023 2:12:17 PM |
Most of volume came from pre market trading | Max2121 | investorshub | 01/20/2023 1:41:45 AM |
shorts are feeling the pain onGNS but that | TheFinalCD | investorshub | 01/20/2023 12:46:31 AM |
Don't surprise me any this market is getting | hawkshaw812 | investorshub | 01/19/2023 10:46:22 PM |
Very | INFINITI | investorshub | 01/19/2023 9:52:24 PM |
News, Short Squeeze, Breakout and More Instantly...
XORTX Therapeutics Inc. Company Name:
XRTX Stock Symbol:
NASDAQ Market:
XORTX Therapeutics Inc. Website:
CALGARY, June 04, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to anno...
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive ...